- freely available
The Innate Immune Playbook for Restricting West Nile Virus Infection
AbstractWest Nile virus (WNV) is an emerging mosquito-borne flavivirus that causes annual epidemics of encephalitic disease throughout the world. Despite the ongoing risk to public health, no approved vaccines or therapies exist for use in humans to prevent or combat WNV infection. The innate immune response is critical for controlling WNV replication, limiting virus-induced pathology, and programming protective humoral and cell-mediated immunity to WNV infection. The RIG-I like receptors, Toll-like receptors, and Nod-like receptors detect and respond to WNV by inducing a potent antiviral defense program, characterized by production of type I IFN, IL-1β and expression of antiviral effector genes. Recent research efforts have focused on uncovering the mechanisms of innate immune sensing, antiviral effector genes that inhibit WNV, and countermeasures employed by WNV to antagonize innate immune cellular defenses. In this review, we highlight the major research findings pertaining to innate immune regulation of WNV infection.
Share & Cite This Article
Quicke, K.M.; Suthar, M.S. The Innate Immune Playbook for Restricting West Nile Virus Infection. Viruses 2013, 5, 2643-2658.View more citation formats
Quicke KM, Suthar MS. The Innate Immune Playbook for Restricting West Nile Virus Infection. Viruses. 2013; 5(11):2643-2658.Chicago/Turabian Style
Quicke, Kendra M.; Suthar, Mehul S. 2013. "The Innate Immune Playbook for Restricting West Nile Virus Infection." Viruses 5, no. 11: 2643-2658.
Notes: Multiple requests from the same IP address are counted as one view.